These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36726960)

  • 1. Interval time between neoadjuvant chemotherapy and surgery in advanced gastric cancer doesn't affect outcome: A meta analysis.
    Zhai Y; Zheng Z; Deng W; Yin J; Bai Z; Liu X; Zhang J; Zhang Z
    Front Surg; 2022; 9():1047456. PubMed ID: 36726960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.
    Ling Q; Huang ST; Yu TH; Liu HL; Zhao LY; Chen XL; Liu K; Chen XZ; Yang K; Hu JK; Zhang WH
    World J Surg Oncol; 2023 Dec; 21(1):377. PubMed ID: 38037067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.
    Lin G; Han SY; Xu YP; Mao WM
    Dis Esophagus; 2016 Nov; 29(8):1107-1114. PubMed ID: 26542065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to surgery does not affect oncologic outcomes in locally advanced gastric cancer after neoadjuvant chemotherapy: a meta-analysis.
    Liu Z; Zhang Z; Liu H; Chen J
    Future Oncol; 2023 Feb; 19(5):397-408. PubMed ID: 36919890
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and Safety of Minimally Invasive Surgery Versus Open Laparotomy for Interval Debulking Surgery of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A Systematic Review and A Meta-Analysis.
    Zeng S; Yu Y; Cui Y; Liu B; Jin X; Li Z; Liu L
    Front Oncol; 2022; 12():900256. PubMed ID: 35924170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Interval between Neoadjuvant Chemotherapy and Gastrectomy on Pathological Response and Survival Outcomes for Patients with Locally Advanced Gastric Cancer: A Meta-analysis.
    Naveed S; Banday SZ; Qari H; Zahoor S; Batoo AJ; Wahid MA; Haq MFU
    Euroasian J Hepatogastroenterol; 2022; 12(2):81-91. PubMed ID: 36959991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery.
    Wan XB; Zhang Q; Chen M; Liu Y; Zheng J; Lan P; He F
    Front Oncol; 2020; 10():1280. PubMed ID: 32974129
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of the Time Interval from Neoadjuvant Chemotherapy to Surgery in Primary Ovarian, Tubal, and Peritoneal Cancer Patients.
    Chen M; Chen Z; Xu M; Liu D; Liu T; He M; Yao S
    J Cancer; 2018; 9(21):4087-4091. PubMed ID: 30410613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Laparoscopic Versus Open Gastrectomy in Patients With Advanced Gastric Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis.
    Liao XL; Liang XW; Pang HY; Yang K; Chen XZ; Chen XL; Liu K; Zhao LY; Zhang WH; Hu JK
    Front Oncol; 2021; 11():704244. PubMed ID: 34422658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
    Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
    PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.
    Chen JB; Liu ZN; Wang YK; Shan F; Li SX; Jia YN; Xue K; Miao RL; Li ZM; Wu ZQ; Ying XJ; Zhang Y; Li ZY; Ji JF
    Front Oncol; 2022; 12():956706. PubMed ID: 36620591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph Node Yield in Gastrointestinal Cancer Surgery With or Without Prior Neoadjuvant Therapy: Protocol for a Systematic Review and Meta-analysis.
    Ronellenfitsch U; Mathis N; Friedrichs J; Kleeff J
    JMIR Res Protoc; 2022 Apr; 11(4):e35243. PubMed ID: 35482374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
    Wang Y; Liu Z; Shan F; Ying X; Zhang Y; Li S; Jia Y; Li Z; Ji J
    Front Oncol; 2020; 10():613988. PubMed ID: 33392098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: A systematic review and meta-analysis.
    Liang Z; Li Z; Yang Q; Feng J; Xiang D; Lyu H; Mai G; Wang W
    Front Oncol; 2022; 12():1024345. PubMed ID: 36313637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefits from neoadjuvant treatment in gastric cancer: a systematic review and meta-analysis.
    Hu J; Yang Y; Ma Y; Ning Y; Chen G; Liu Y
    Syst Rev; 2022 Jul; 11(1):136. PubMed ID: 35788246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies.
    Petrelli F; Sgroi G; Sarti E; Barni S
    Ann Surg; 2016 Mar; 263(3):458-64. PubMed ID: 24263329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does time to esophagectomy following neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma affect outcomes?
    Hong ZN; Huang Z; Weng K; Lin J; Kang M
    Front Immunol; 2022; 13():1036396. PubMed ID: 36311738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 20. The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis.
    Wang T; Li C; Li X; Zhai J; Wang S; Shen L
    Eur J Med Res; 2022 Nov; 27(1):239. PubMed ID: 36352476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.